Literature DB >> 16012036

Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires.

M Okuda1, K Ohkubo, M Goto, H Okamoto, A Konno, K Baba, S Ogino, M Enomoto, T Imai, N So, Y Ishikawa, Y Takenaka, T Manndai, B Crawford.   

Abstract

CONCLUSION: Two questionnaires were used to assess quality of life (QOL) in allergic rhinitis: the Japanese translation of the Rhino-conjunctivitis Quality of Life Questionnaire (RQLQJ) and an original Japanese QOL questionnaire (JRQLQ). Either questionnaire may be used to assess QOL depending on differences in target domains.
OBJECTIVES: Although pollinosis is a common disease which has a major impact on patient QOL, no internationally standardized questionnaire has been available in Japan until now. The aim of this study was to compare two currently available QOL questionnaires for allergic rhinitis in Japan-the RQLQJ and JRQLQ-in terms of their appropriateness for clinical use and their psychometric properties.
MATERIAL AND METHODS: A multicenter, inter-group, cross-sectional study was conducted in 187 adult symptomatic patients with Japanese cedar pollinosis in 2003. Patient scores on the two questionnaires were compared in terms of both overall and comparable domains. We also examined the acceptability, construct and reliability of both questionnaires.
RESULTS: The questionnaires were highly correlated in terms of both overall and comparable domain scores. In addition, both questionnaires had equal and satisfactory psychometric validity, demonstrating that they are both useful tools for assessing QOL in rhinitis. However, when compared with each other, the JRQLQ focuses mainly on activities of daily life and is simpler, while the RQLQJ focuses mainly on rhinitis-related health and is more responsive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012036     DOI: 10.1080/00016480510026944

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Efficacy of chlorophyll c2 for seasonal allergic rhinitis: single-center double-blind randomized control trial.

Authors:  Takashi Fujiwara; Naoya Nishida; Jumpei Nota; Takashi Kitani; Kunihide Aoishi; Hirotaka Takahashi; Takuya Sugahara; Naohito Hato
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-09       Impact factor: 2.503

2.  Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Authors:  Kazuki Fujioka; Akiko Kasahara; Takashi Kida; Wataru Fujii; Takahiro Seno; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-11       Impact factor: 3.373

3.  Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice.

Authors:  Mitsuko Yuzawa; Kyoko Fujita; Erika Tanaka; Edward C Y Wang
Journal:  Clin Ophthalmol       Date:  2013-07-01

4.  A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.

Authors:  K Okubo; K Hashiguchi; T Takeda; K Baba; H Kitagoh; H Miho; H Tomomatsu; S Yamaguchi; M Odani; H Yamamotoya
Journal:  Allergy       Date:  2017-05-16       Impact factor: 13.146

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.